Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ALVO — Alvotech

CIK 1214717 BOSTON, MA
Back to ALVO Full portfolio

Position in ALVO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,096,893
-$15,109 QoQ
Shares Held
297,261
-8.3% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 72 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. ALVO ranks #43 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 13,289,622 $954,992,236
2 UTHR
UNITED THERAPEUTICS Corp
 996,598 $539,986,694
3 VTRS
Viatris Inc
 32,807,906 $520,989,547
4 TEVA
Teva Pharmaceutical Industries Ltd
 11,607,196 $393,251,799
5 NBIX
Neurocrine Biosciences Inc
 2,138,777 $360,469,474
6 ELAN
Elanco Animal Health Inc
 11,302,057 $278,143,622
7 ALKS
Alkermes plc.
 4,477,876 $234,640,702
8 LNTH
Lantheus Holdings, Inc.
 1,841,367 $204,281,254

All Filings in ALVO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,096,893 297,261
2026-03-31 $1,112,002 324,199
2025-12-31 $1,307,744 254,921
2025-09-30 $1,885,780 230,254
2025-06-30 $2,100,253 230,291
2025-03-31 $2,211,693 228,717
2024-12-31 $2,878,676 217,587
2024-09-30 $2,490,158 209,257
2024-06-30 $2,288,937 188,235
2024-03-31 $1,625,211 132,996
2023-12-31 $742,354 64,665
2023-09-30 $519,849 57,001
2023-06-30 $300,691 38,849
2023-03-31 $438,690 34,007